Title of article
Impact of Clopidogrel on Suppression of Circulating Levels of Soluble CD40 Ligand in Patients With Unstable Angina Undergoing Coronary Stenting
Author/Authors
Yip، نويسنده , , Hon-Kan and Chang، نويسنده , , Li-Teh and Sun، نويسنده , , Cheuk-Kwan and Yang، نويسنده , , Cheng-Hsu and Hung، نويسنده , , Wei-Chin and Cheng، نويسنده , , Cheng-I. and Chua، نويسنده , , Sarah and Yeh، نويسنده , , Kuo-Ho and Wu، نويسنده , , Chiung-Jen and Fu، نويسنده , , Morgan، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
3
From page
192
To page
194
Abstract
This study investigated whether a regimen that comprised a loading dose of 300 mg of clopidogrel followed by 75 mg/day could significantly suppress circulating levels of soluble CD40 ligand (sCD40L) in patients who had unstable angina and underwent coronary stenting. Study results showed that the clopidogrel loading dose substantially decreased the circulating level of sCD40L at 24 hours after stenting (p <0.0001). Combined with aspirin, 75 mg/day of clopidogrel continuously decreased sCD40L levels after coronary stenting.
Journal title
American Journal of Cardiology
Serial Year
2006
Journal title
American Journal of Cardiology
Record number
1900365
Link To Document